Lichen sclerosus

Dermatologic Clinics

Volumn 28, Issue 4, 2010, Pages 707-715

  Murphy, Ruth ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Childhood lichen sclerosus; Differentiated vulvar intraepithelial neoplasia; Lichen sclerosus; Vulva

Indexed keywords

CLOBETASOL PROPIONATE; HLA ANTIGEN; T LYMPHOCYTE RECEPTOR;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG TREATMENT FAILURE; DYSESTHESIA; DYSPAREUNIA; ENVIRONMENTAL FACTOR; FOLLOW UP; GENE REARRANGEMENT; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; PATHOGENESIS; PHIMOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCAR FORMATION; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DYSPAREUNIA; FEMALE; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; PROGNOSIS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT FAILURE; VULVA; VULVAR NEOPLASMS;

EID: 77957164823     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2010.07.006     Document Type: Review

References (57)

1. Hallopeau H. Lecons Clinique sur les maladies cutanees et syphilitique. L'Union Medicale 1887, 43:742-747. [in French].
2. Hallopeau H. Lichen plan sclereux. Ann Dermatol Syph 1889, 10:447-449. [in French].
3. Darier J. Lichen plan sclereux. Ann Dermatol Syph 1892, 3:833-837. [in French].
4. Neill S.M., Tatnall F.M., Cox N.H. Guidelines for the management of Lichen sclerosus. Br J Dermatol 2002, 147(4):640-649.
5. Clarke J., Etherington I.J., Luesley D. Response of vulvar lichen sclerosus and squamous cell hyperplasia to graduated topical steroids. J Reprod Med 1999, 44:958-962.
6. Harrington C.I., Dunsmore J.R. An Investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol 1981, 109:661-664.
7. Meyrick Thomas R.H., Ridley C.M., Black M.M. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol 1983, 109:661-664.
8. Meyrick Thomas R.H., Ridley C.M., Black M.M. Lichen Sclerosus et atrophicus associated with systemic lupus erythematosus. J Am Acad Dermatol 1985, 13:832-833.
9. Meyrick Thomas R.H., Ridley C.M., McGibbon D.H., et al. Lichen Sclerosus et atrophicus and autoimmunity-a study of 350 women. Br J Dermatol 1988, 118:41-46.
10. Cooper S.M., Ali A., Baldo M., et al. The association of LS and erosive LP of the vulva with autoimmune disease. Arch Dermatol 2008, 144:1432-1435.
11. Meyrick Thomas R.H., Ridley C.M., McGibbon D.H., et al. The development of lichen sclerosus et atrophicus in monozygotic twin girls. Br J Dermatol 1986, 114:377-379.
12. Azurdia R.M., Luzzi G.A., Byren I., et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol 1999, 140:79-83.
13. Marren P., Yell J., Charnock F.M., et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995, 132:197-203.
14. Lukowsky A., Muche J.M., Sterry W., et al. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol 2000, 115:254-259.
15. Regauer S., Reich O., Beham-Schmid C. Monoclonal gamma T-cell receptor rearrangement in vulval lichen sclerosus and squamous cell carcinomas. Am J Pathol 2002, 160:1035-1045.
16. Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol 2005, 84:273-277.
17. Regauer S., Beham-Schmid C. Detailed analysis of the T-cell lymphocytic infiltrate in penile lichen sclerosus: an immunohistochemical and molecular investigation. Histopathology 2006, 48:730-735.
18. Oyama N., Chan I., Neill S.M., et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003, 362:118-123.
19. Howard A., Dean D., Cooper S., et al. Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva. Australas J Dermatol 2004, 45(1):12-15.
20. Sander C.S., Ali I., Dean D., et al. Oxidative stress implicated in the pathogenesis of lichen sclerosus. Br J Dermatol 2004, 151:627-635.
21. De Vito J.R., Merogi A.J., Vo T., et al. Role of Borrelia burgdorferi in the pathogenesis of morphoea/scleroderma and lichen sclerosus et atrophicus: a PCR study of thirty five cases. Br J Dermatol 2000, 142:481-484.
22. Fujiwara H., Fujiwara K., Hashimoto K., et al. Detection of Borrelia burgdorferi DNA in (B.garinii or B afzelii) in morphoea and lichen sclerosus et atrophicus tissue of German and Japanese but not US patients. Arch Dermatol 1997, 133:41-44.
23. Farrell A.M., Dean D., Charnock F.M., et al. Alterations in distribution of tenascin, fibronectin and fibrinogen in vulval lichen sclerosus. Dermatology 2000, 201:223-229.
24. Farrell A.M., Dean D., Charnock F.M., et al. Alterations in fibrillin as well as collagens I and III and elastin occur in vulval lichen sclerosus. J Eur Acad Dermatol Venereol 2001, 15:212-217.
25. Ohlenbusch A., Matuschka F.R., Richter D., et al. Etiology of the acrodermatitis chronica atrophicans lesion in Lyme Disease. J Infect Dis 1996, 174(2):421-423.
26. Wallace H.J. Lichen Sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971, 57:9-30.
27. Hodgins M.B., Spike R.C., Mackie R.M., et al. An immunohistochemical evaluation of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998, 105:216-222.
28. Clifton M.M., Garner I.B., Kohler S., et al. Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: evidence for loss of androgen receptors in lesional epidermis: evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol 1999, 41:43-46.
29. Günthert A.R., Faber M., Knappe G. Early onset vulvar LS in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol 2008, 137:56-60.
30. Powell J.J., Wojanorowska F. Lichen sclerosus. Lancet 1999, 353:1777-1783.
31. Lipscombe T.K., Wayte J., Wojnarowska F., et al. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Aust J Dermatol 1997, 38:132-136.
32. Dalziel K. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995, 40:351-354.
33. Marin M.G., King R., Dinnerstein G.I., et al. Dyspareunia and vulval disease. J Reprod Med 1998, 43:952-958.
34. Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001, 44(5):803-806.
35. Maronn M.L., Esterly N.B. Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics 2005, 115(2):230-232.
36. Handfield Jones S.E., Hinde F.R., Kennedy C.T.C. Lichen sclerosus et atrophicus in children misdiagnosed as sexual abuse. Br Med J 1987, 294:1404-1405.
37. Warrington S., San Lazaro C. Lichen sclerosus and sexual abuse. Arch Dis Child 1996, 75:512-516.
38. Simpkin S., Oakley A. Clinical review of 202 patients with lichen sclerosus: a possible association with psoriasis. Australas J Dermatol 2007, 48:28-31.
39. Eberz B., Berghold A., Regauer S., et al. High prevalence of concomitant anogenital LS and extragenital psoriasis in adult women. Obstet Gynecol 2008, 111:1143-1147.
40. Marren P., Millard P.R., Wojnarowska F. Vulval Lichen Sclerosus: lack of correlation between duration of clinical symptoms and histological appearances. J Eur Acad Dermatol Venereol 1997, 8:212-216.
41. Hewitt J. Histologic criteria for lichen sclerosus of the vulva. J Reprod Med 1986, 31:781-787.
42. Regauer S., Liegl B., Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2005, 47:340-347.
43. Paniel B. Surgical procedures in benign vulval disease. The vulva 1999, 288-290. Blackwell Science, Oxford (UK). C.M. Ridley, S.M. Neill (Eds.).
44. Derrick E.K., Ridley C.M., Kobza-Black A., et al. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol 2000, 143:1217-1223.
45. Brisgotti M., Moreno A., Murcia, et al. Verrucous carcinoma of the vulva. A clinicopathologic and immunohistochemical study of 5 cases. Int J Gynecol Pathol 1989, 8:1-7.
46. Meyrick-Thomas R.H., Mc Gibbon D.H., Munro D.D. Basal cell carcinoma of the vulva in association with vulval lichen sclerosus et atrophicus. J R Soc Med 1985, 78:16-18.
47. Friedman R.J., Kopf A.W., Jones W.B. Malignant melanoma in association with lichen sclerosus on the vulva of a 14 year old. Am J Dermatopathol 1984, 6:253-256.
48. Giles C.G., Kneale B.L. Vulvar cancer. The Cinderella of gynaecological oncology. Aust N Z J Obstet Gynaecol 1995, 35:71-75.
49. Hart W.R., Norris H.J., Helwig E.B. Relation of lichen sclerosus et atrophicus of the vulva to development of carcinoma. Obstet Gynecol 1975, 45:369-377.
50. Leibowitch M., Neill S., Pelisse M., et al. The epithelial changes associated with squamous cell carcinoma of the vulva. A review of the clinical, histologic and viral findings in 78 women. Br J Obstet Gynaecol 1990, 97:1135-1139.
51. Crum C.P., Mc Lachlin C.M., Tate J.E., et al. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynaecol 1997, 9:63-69.
52. Carli P., Cattaneo A., De Magnis A., et al. Squamous cell carcinoma arising in lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995, 4:491-495.
53. Haefner H.K., Tate J.E., McLachelin C.M., et al. Vulvar intraepithelial neoplasia:age, morphological phenotype, papillomavirus DNA, and co-existing invasive carcinoma. Hum Pathol 1995, 26:147-154.
54. Hengge W., Krause W., Hoffman H., et al. Multicentre, phase II trial on the safety and efficacy of topical Tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006, 155:1021-1028.
55. Helm K.F., Gibson L.E., Muller S.A. Lichen sclerosus et atrophicus in children and young adults. Pediatr Dermatol 1991, 8(2):97-101.
56. Powell J., Wojnarowska F., Winsey S., et al. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000, 142:481-484.
57. Powell J., Wojnarowska F. Childhood vulvar lichen sclerosus. The course after puberty. J Reprod Med 2002, 47(9):706-709.